BFLY vs. LMAT, NVCR, EYE, ENOV, CNMD, TNDM, CDRE, AORT, LQDA, and FNA
Should you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include LeMaitre Vascular (LMAT), NovoCure (NVCR), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), Tandem Diabetes Care (TNDM), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), and Paragon 28 (FNA). These companies are all part of the "medical equipment" industry.
Butterfly Network vs. Its Competitors
Butterfly Network (NYSE:BFLY) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.
37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by company insiders. Comparatively, 9.5% of LeMaitre Vascular shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Butterfly Network has a beta of 2.46, meaning that its share price is 146% more volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
LeMaitre Vascular has a net margin of 19.96% compared to Butterfly Network's net margin of -75.56%. LeMaitre Vascular's return on equity of 13.53% beat Butterfly Network's return on equity.
In the previous week, Butterfly Network had 6 more articles in the media than LeMaitre Vascular. MarketBeat recorded 7 mentions for Butterfly Network and 1 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.73 beat Butterfly Network's score of 0.34 indicating that LeMaitre Vascular is being referred to more favorably in the news media.
Butterfly Network presently has a consensus price target of $3.50, indicating a potential upside of 75.44%. LeMaitre Vascular has a consensus price target of $97.83, indicating a potential upside of 15.90%. Given Butterfly Network's stronger consensus rating and higher possible upside, analysts clearly believe Butterfly Network is more favorable than LeMaitre Vascular.
LeMaitre Vascular has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.
Summary
LeMaitre Vascular beats Butterfly Network on 10 of the 16 factors compared between the two stocks.
Get Butterfly Network News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BFLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Butterfly Network Competitors List
Related Companies and Tools
This page (NYSE:BFLY) was last updated on 7/4/2025 by MarketBeat.com Staff